Jump to navigation
By Dr. Unni Karunakara, incoming president of MSF's International Council, and Dr. Bernard Pecoul, executive director of the Drugs for Neglected Diseases initiative
By Dr. Rony Brauman, is the former President of MSF in France and is currently a Research Director at CRASH, MSF's center for reflection on humnaitarian action.
By Jeanne Cabeza, MSF medical coordinator in Haiti, and Michelle Chouinard, MSF head of mission in Haiti
by Rony BRAUMAN Former president of MSF-France Associate Professor at the Institute of Political Studies in Paris
By Dr. Tido von Schoen-Angerer Executive director Access to Essential Medicines Campaign Doctors Without Borders
By Susan Shepherd The New York Times
The public sector has a key role in drug R&D. Patenting minor changes to extend monopoly prices spells misuse By Dr. Brian Druker
Dr. Buddhima Lokuge U.S. manager, Access to Essential Medicines Campaign
By David Wilson Medical Coordinator, Doctors Without Borders/Médecins Sans Frontieres
333 7th Avenue, New York, NY 10001-5004
A 501(c)(3) tax-exempt organization. Federal Identification Number (EIN): 13-3433452.